Prior authorization, a longtime bane of providers, is on track to become less burdensome thanks to a new Centers for Medicare & Medicaid Services (CMS) proposed rule. The good news is the rule includes Medicare Advantage, which was left out of a previous version. But results, already delayed once, may still come slowly.

On December 6th, CMS announced a proposed rule, “Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations,” which replaces the previous CMS rule from 2020. Some key aspects of the rule include: increased transparency into prior authorization decisions; quicker turnaround times for said decisions; and automating certain processes that remain heavily manual to this day. 

Cohere Health’s Alina M. Czekai, Vice President of Strategic Partnerships & former Senior Advisor to CMS Administrator Seema Verma, who worked on the original rule, sat down with Roy Edroso, Editor, Part B News, to discuss how this new initiative would improve transparency within the prior authorization process, reduce physician burden, and result in faster access to patient care.

Published On: December 19th, 2022Categories: News

Share:

About the Author: Cohere Health

Cohere Health is a clinical intelligence company delivering AI-powered intelligent prior authorization solutions, which streamlines patients’ access to quality care by aligning their physicians and health plans for improved collaboration, transparency, and care coordination. Cohere works with nearly 600,000 providers and processes more than 12 million prior authorization requests annually, using AI to auto-approve up to 90% of requests for millions of health plan members around the country. The company was recognized twice in the Gartner® Hype Cycle™ for U.S. Healthcare Payers, is a Top 5 LinkedIn™ Startup for 2023 & 2024, and is a three-time KLAS Points of Light award recipient. Its investors include Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners.